Danaher Schedules First Quarter 2025 Earnings Conference Call
Rhea-AI Summary
Danaher (NYSE: DHR) has announced its upcoming first quarter 2025 earnings conference call, scheduled for Tuesday, April 22, 2025, at 8:00 a.m. ET. The hour-long presentation will include discussions on financial performance and future expectations.
The event will be accessible through a webcast on Danaher's website under the 'Investors' section, accompanied by slide presentations. Participants can join via phone by dialing 800-245-3047 (U.S.) or +1 203-518-9765 (international) using Conference ID: DHRQ125.
A replay will be available until May 6, 2025. The earnings press release, webcast slides, and related materials will be posted on Danaher's website at 6:00 a.m. ET on the day of the call.
Positive
- None.
Negative
- None.
News Market Reaction – DHR
In the trading session that priced this news, DHR gained 0.53%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.
You can access the conference call by dialing 800-245-3047, within the
Danaher's earnings press release, the webcast slides and other related materials will be posted to the "Investors" section of Danaher's website under the subheading "Quarterly Earnings" beginning at 6:00 a.m. ET on the date of the earnings call and will remain available following the call.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-schedules-first-quarter-2025-earnings-conference-call-302407216.html
SOURCE Danaher Corporation